PACB

Pacific Biosciences of California, Inc. (NASDAQ:PACB) is a biotechnology company founded in 2000 and headquartered in Menlo Park, California. Originally incorporated as Nanofluidics, Inc., the company changed its name to Pacific Biosciences in 2005 and went public in 2010. PacBio specializes in developing and manufacturing advanced DNA sequencing systems that enable researchers to decode complex genetic information with unprecedented accuracy and detail. The company has evolved from a research-focused organization to a commercial enterprise serving academic institutions, clinical laboratories, and pharmaceutical companies worldwide, though it continues to face profitability challenges while pursuing technological innovation in the genomics field.